Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001153 · ClinicalTrials.gov registry record
Visual Function and Ocular Pigmentation in Albinism
A clinical trial of Albinism and Albinism, Ocular, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT00001153 is a study of Albinism and Albinism, Ocular that has completed, run by National Eye Institute (NEI). The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00001153, a study of Albinism and Albinism, Ocular, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the relationship between visual function and ocular (iris, retina/choroidal) pigmentation in patients with albinism and other hypomelanotic disorders. To identify the carrier state in relatives of patients with ocular albinism.
Conditions Studied
Study Locations (1)
Maryland
- National Eye Institute (NEI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 1976-06 |
| Est. Completion | 2000-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001153
The ClinicalTrials.gov registry entry for NCT00001153 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Albinism appearing as the primary indexed condition, and to 0 interventions.
NCT00001153 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001153 about?
NCT00001153 is a clinical study titled "Visual Function and Ocular Pigmentation in Albinism". To study the relationship between visual function and ocular (iris, retina/choroidal) pigmentation in patients with albinism and other hypomelanotic disorders. To identify the carrier state in relatives of patients with ocular albinism.
What is the current status of trial NCT00001153?
This trial is currently completed. The enrollment target is 130 participants. The study started on 1976-06. Estimated completion is 2000-05.
What conditions does trial NCT00001153 study?
This clinical trial studies the following conditions: Albinism, Albinism, Ocular, Albinism, Oculocutaneous.
Who is sponsoring clinical trial NCT00001153?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001153 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Albinism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.